$1.75 Billion is the total value of BRIDGER MANAGEMENT, LLC's 37 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
WMGI | Sell | WRIGHT MED GROUP N V | $82,632,000 | +12.7% | 2,655,256 | -16.8% | 4.72% | -7.5% |
NKTR | Sell | NEKTAR THERAPEUTICS | $68,937,000 | +42.4% | 2,937,255 | -25.5% | 3.93% | +16.9% |
AGN | Sell | ALLERGAN PLC | $66,850,000 | -0.7% | 279,799 | -12.7% | 3.81% | -18.5% |
CNC | Sell | CENTENE CORP DEL | $59,991,000 | +4.2% | 841,854 | -17.3% | 3.42% | -14.4% |
MGM | Sell | MGM RESORTS INTERNATIONAL | $55,422,000 | -31.5% | 2,022,700 | -28.0% | 3.16% | -43.8% |
TGTX | Sell | TG THERAPEUTICS INC | $53,855,000 | +135.3% | 4,622,749 | -6.1% | 3.07% | +93.1% |
CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $45,199,000 | -18.4% | 138,087 | -28.2% | 2.58% | -33.0% |
INCY | Sell | INCYTE CORP | $37,117,000 | -27.4% | 277,674 | -45.6% | 2.12% | -40.4% |
LBRDA | Sell | LIBERTY BROADBAND CORP | $33,210,000 | +5.1% | 390,292 | -10.5% | 1.90% | -13.7% |
IRWD | Sell | IRONWOOD PHARMACEUTICALS INC | $26,761,000 | -6.9% | 1,568,622 | -16.5% | 1.53% | -23.6% |
CMG | Exit | CHIPOTLE MEXICAN GRILL INCcall | $0 | – | -30,000 | -100.0% | -0.79% | – |
KSU | Exit | KANSAS CITY SOUTHERN | $0 | – | -449,703 | -100.0% | -2.65% | – |
MRK | Exit | MERCK & CO INC | $0 | – | -864,371 | -100.0% | -3.54% | – |
AET | Exit | AETNA INC NEW | $0 | – | -413,536 | -100.0% | -3.56% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -355,036 | -100.0% | -3.95% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.